19 results

• Gilead Settles HIV Drug Lawsuit Over Patent on Truvada and Descovy

  January 20, 2025

  Irvin Jackson

  The U.S. and Gilead have reached a settlement agreement involving patent rights to two HIV drugs, Truvada and Descovy, which are used as pre-exposure prophylaxis treatments to prevent the spread of HIV.

• U.S. Government Files Appeal Over Gilead Truvada, Descovy HIV Drug Patents

  July 10, 2024

  Irvin Jackson

  The U.S. government has asked a federal appeals court to overturn a 2023 jury verdict, which rejected claims that Gilead illegally profited from its patent on certain HIV drugs that the CDC helped the manufacturer develop.

• HIV Drug Descovy May Increase Risk of High Blood Pressure: Study

  September 22, 2023

  Irvin Jackson

  Kaiser Permanente researchers warn that the side effects of Descovy could result in an increased risk of hypertension and the need for cholesterol control.

• U.S. Task Force Finds “High Benefit” from Use of HIV Drugs for Prevention

  August 24, 2023

  Irvin Jackson

  A federal task force is recommending widespread use of Gilead HIV drugs as preventative measures to those at high risk of exposure.

• Lawsuit Over Atripla, Truvada Pay-to-Delay Generics Scheme Results in Defense Verdict for Gilead, Teva

  July 10, 2023

  Irvin Jackson

  Gilead and Teva are not liable for antitrust violations which insurers and other drug purchasers said was a "pay-to-delay" scheme designed to illegally maximize the manufacturers' profits.

• Government’s Gilead HIV Drug Lawsuit Over Patent Rights Ends in Defense Verdict

  May 10, 2023

  Irvin Jackson

  A jury reached a defense verdict on Tuesday in a patent lawsuit filed by the U.S. government over Gilead's HIV drugs.

• Lawsuit Alleges Side Effects of Atripla, Stribild and Other HIV Drugs Endangered Patients to Increase Gilead Profits

  October 5, 2022

  Irvin Jackson

  A lawsuit filed by 20 plaintiffs claims Gilead held back safer formulations of its HIV drugs in order to maximize profits at the expense of their kidneys and other health risks.

• Gilead HIV Drug Health Risks Were Known Before First TDF-Based Antiretrovirals Hit The Market: Lawsuit

  February 7, 2022

  Irvin Jackson

  Gilead knew its HIV drugs carried severe health risks before the first ones were placed on the market, the lawsuit claims.

• HIV Drug Settlement Reached to Resolve Class Action Over Truvada, Stribild, Other Antiretrovirals

  January 3, 2022

  Irvin Jackson

  One drug manufacturer has agreed to pay $10 million to resolve its part in allegations that Gilead and other drug makers conspired to keep HIV medication prices artificially high.

• Gilead TDF Lawsuit Alleges Toxic Effects of HIV Drugs on Bones, Kidneys Was Known For Years

  December 30, 2021

  Irvin Jackson

  A Gilead TDF lawsuit involving about 80 plaintiffs alleges the drug maker exposed patients unnecessarily to toxic effects of its HIV drugs when it had a safer formulation available.